Hao Tian Management (Hong Kong) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。